606 related articles for article (PubMed ID: 17126656)
21. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
22. Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake.
Michaels AD; McKeown B; Kostal M; Vakharia KT; Jordan MV; Gerber IL; Foster E; Chatterjee K
Circulation; 2005 Mar; 111(12):1504-9. PubMed ID: 15781741
[TBL] [Abstract][Full Text] [Related]
23. Levosimendan and pulmonary hypertension.
Cavusoglu Y; Beyaztas A; Birdane A; Ata N
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):478-80. PubMed ID: 20516805
[No Abstract] [Full Text] [Related]
24. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
25. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
[TBL] [Abstract][Full Text] [Related]
26. Management of acute cardiac failure by intracoronary administration of levosimendan.
Caimmi PP; Kapetanakis EI; Beggino C; Molinari C; Giustini G; Crosio E; Reposo G; Micalizzi E; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Sep; 58(3):246-53. PubMed ID: 21654504
[TBL] [Abstract][Full Text] [Related]
27. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
Despas F; Trouillet C; Franchitto N; Labrunee M; Galinier M; Senard JM; Pathak A
Acute Card Care; 2010 Mar; 12(1):25-30. PubMed ID: 19929264
[TBL] [Abstract][Full Text] [Related]
28. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
[TBL] [Abstract][Full Text] [Related]
29. Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failure.
Berger R; Moertl D; Huelsmann M; Bojic A; Ahmadi R; Heissenberger I; Pacher R
Eur J Heart Fail; 2007 Feb; 9(2):202-8. PubMed ID: 16859992
[TBL] [Abstract][Full Text] [Related]
30. Preoperative treatment with levosimendan in candidates for mechanical circulatory support.
Sponga S; Ivanitskaia E; Potapov E; Krabatsch T; Hetzer R; Lehmkuhl H
ASAIO J; 2012; 58(1):6-11. PubMed ID: 22157071
[TBL] [Abstract][Full Text] [Related]
31. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
32. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
[TBL] [Abstract][Full Text] [Related]
33. Levosimendan: dual mechanisms for acute heart failure...and beyond?
Ng TM; Akhter MW
Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
[TBL] [Abstract][Full Text] [Related]
34. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
[TBL] [Abstract][Full Text] [Related]
35. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
Poelzl G; Zwick RH; Grander W; Metzler B; Jonetzko P; Frick M; Ulmer H; Pachinger O; Roithinger FX
Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157
[TBL] [Abstract][Full Text] [Related]
36. Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy.
Guarracino F; Cariello C; Danella A; Doroni L; Lapolla F; Stefani M; Baldassarri R; Vullo C
Acta Anaesthesiol Scand; 2007 Oct; 51(9):1217-24. PubMed ID: 17850562
[TBL] [Abstract][Full Text] [Related]
37. Delayed improvement of right ventricular diastolic function and regression of right ventricular mass after percutaneous pulmonary valve implantation in patients with congenital heart disease.
Romeih S; Kroft LJ; Bokenkamp R; Schalij MJ; Grotenhuis H; Hazekamp MG; Groenink M; de Roos A; Blom NA
Am Heart J; 2009 Jul; 158(1):40-6. PubMed ID: 19540390
[TBL] [Abstract][Full Text] [Related]
38. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
Cavana M; Pignataro C; Fraticelli A; Mebazaa A
Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
[TBL] [Abstract][Full Text] [Related]
39. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
Husedzinović I; Barisin S; Bradić N; Barisin A; Sonicki Z; Milanović R
Croat Med J; 2005 Dec; 46(6):950-6. PubMed ID: 16342349
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure.
Malfatto G; Della Rosa F; Rella V; Villani A; Branzi G; Blengino S; Giglio A; Facchini M; Parati G
J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):322-30. PubMed ID: 24699010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
